Showing results (2241-2250 of 2,259) with videos related to
Sort By:
Pageof 226
Cell Reports|November 24, 2021
Identification of a gut microbiota member that ameliorates DSS-induced colitis in intestinal barrier enhanced Dusp6-deficient miceCherng-Shyang Chang, Yi-Chu Liao, Chih-Ting Huang, et al.Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.Journal of Environmental Management|June 16, 2026
Not the same plastics: Comparing abundance and composition of marine macro-litter in mangroves and beaches in Southeast AsiaJenny Fong, Ashwini Suresh Kumar, Cheng Ling Lim, et al.Bioorganic Chemistry|March 2, 2018
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacyShu-Yu Lin, Teng-Kuang Yeh, Jen-Shin Song, et al.Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.Journal of Neurointerventional Surgery|November 19, 2025
Comaneci-assisted embolization of wide-necked aneurysms: results from the SUCCESS postmarket US studyJason M Davies, Muhammad Asif Taqi, Alexander L Coon, et al.European Journal of Medicinal Chemistry|December 20, 2021
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug designTeng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.World Journal of Pediatrics : WJP|October 30, 2021
Evaluation of a new frequency-volume chart for children with primary monosymptomatic nocturnal enuresis: a prospective, comparative studyJing-Jing Wang, Dong-Jie Wang, Hai-Dong Fu, et al.Pageof 226